Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective This study investigates the cost-effectiveness of gestational diabetes mellitus (GDM) screening using the new IADPSG guidelines. Study Design A decision analytic model was built comparing routine screening with the 2h OGTT vs. the 1-hour GCT. All probabilities, costs, and benefits were derived from the literature. Base-case, sensitivity analyses, and a Monte Carlo simulation were performed. Results Screening with the 2h GTT was more expensive, more effective, and cost-effective at $61,503/QALY. In a one-way sensitivity analysis, the more inclusive IADPSG diagnostic approach remained cost-effective as long an additional 2.0% or more of patients were diagnosed and treated for GDM. Conclusion Screening at 24-28 weeks GA under the new IADPSG guidelines with the 2h GTT is expensive but cost-effective in improving maternal and neonatal outcomes. How the health care system will provide expanded care to this group of women will need to be examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 6×
“Their analyses assumed that the benefits of GDM treatment would translate to the additional patients who would newly qualify for a GDM diagnosis under the new IADPSG criteria.31 To calculate the effects of treatment on cesarean section and other outcomes, this group used the results from a recent metaanalysis on perin…”
MethodInfluentialEffect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 8×
“Their analyses assumed that the benefits of GDM treatment would translate to the additional patients who would newly qualify for a GDM diagnosis under the new IADPSG criteria.31 To calculate the effects of treatment on cesarean section and other outcomes, this group used the results from a recent metaanalysis on perin…”
BackgroundMethodInfluentialMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Hyperglycemia and Adverse Pregnancy Outcomes
Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., Hadden, D. R., McCance, D. R., Hod, M., McIntyre, H. D., et al. (2009) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000344706.95925.dc · Cited by 479
Horvath, K., Koch, K., Jeitler, K., Matyas, E., Bender, R., Bastian, H., Lange, S., & Siebenhofer, A. (2010) · BMJ · doi:10.1136/bmj.c1395 · Cited by 359 · cited 7×
“Their analyses assumed that the benefits of GDM treatment would translate to the additional patients who would newly qualify for a GDM diagnosis under the new IADPSG criteria.31 To calculate the effects of treatment on cesarean section and other outcomes, this group used the results from a recent metaanalysis on perin…”
MethodInfluentialEsakoff, T. F., Cheng, Y. W., Sparks, T. N., & Caughey, A. B. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.02.035 · Cited by 264
Self-citationWerner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182 · cited 4×
“Prior cost analyses have investigated the effectiveness of using the 2h OGTT in comparison to the 1h GCT using the new IADPSG guidelines.(18,31) One prior analsis looking at using the 2h OGTT comared the cost of the 2h OGTT screening additional gestational diabetes mellitus (GDM) test (OGTT).”
MethodResultInfluentialHyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia
(2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.01.024 · Cited by 155
Research works printed but not linked: 25
- Hillier, 2008, Screening for gestational diabetes mellitus: a systematic review for the US Preventive Services Task Force, Ann Intern Med, 148, 766, 10.7326/0003-4819-148-10-200805200-00009 · DOI · Paper page
- Landon, 2011, Gestational diabetes mellitus, Obstet Gynecol, 118, 1379, 10.1097/AOG.0b013e31823974e2 · DOI · Paper page
- Poncet, 2002, Cost-effectiveness analysis of gestational diabetes mellitus screening in France, Eur J Obstet Gynecol Reprod Biol, 103, 122, 10.1016/S0301-2115(02)00042-8 · DOI
- Landon, 2010, Is there a benefit to the treatment of mild gestational diabetes mellitus?, Am J Obstet Gynecol, 202, 649, 10.1016/j.ajog.2010.02.006 · DOI
- Caughey, 2005, Cost-effectiveness analysis of prenatal diagnosis: methodological issues and concerns, Gynecol Obstet Invest, 60, 11, 10.1159/000083480 · DOI
- Rouse, 1999, Prophylactic cesarean delivery for fetal macrosomia diagnosed by means of ultrasonography–a Faustian bargain?, Am J Obstet Gynecol, 181, 332, 10.1016/S0002-9378(99)70557-0 · DOI
- Clark, 2008, Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery, Am J Obstet Gynecol, 199, 36.e1, 10.1016/j.ajog.2008.03.007 · DOI · Paper page
- Kitzmiller, 2000, Cost analysis of diagnosis and treatment of gestational diabetes mellitus, Clin Obstet Gynecol, 43, 140, 10.1097/00003081-200003000-00014 · DOI
- Meltzer, 2010, Gestational diabetes mellitus screening and diagnosis: a prospective randomized controlled trial comparing costs of one-step and two-step methods, BJOG, 117, 407, 10.1111/j.1471-0528.2009.02475.x · DOI · Paper page
- Meads, 2008, Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modeling, Health Technol Assess, 12, iii, 10.3310/hta12060 · DOI · Paper page
- Bost, 2003, Cesarean delivery on demand: what will it cost?, Am J Obstet Gynecol, 188, 1418, 10.1067/mob.2003.455 · DOI
- Lloyd, 2009, Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK, Curr Med Res Opin, 25, 599, 10.1185/03007990802668208 · DOI
- Suresh, 2004, Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants, Pediatrics, 114, 917, 10.1542/peds.2004-0899 · DOI
- Phibbs, 2006, Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants, Early Hum Dev, 82, 85, 10.1016/j.earlhumdev.2006.01.001 · DOI · Paper page
- Culligan, 2005, Elective cesarean section to prevent anal incontinence and brachial plexus injuries associated with macrosomia–a decision analysis, Int Urogynecol J Pelvic Floor Dysfunct, 16, 19, 10.1007/s00192-004-1203-3 · DOI
- Grobman, 2000, Cost-effectiveness of elective cesarean delivery after one prior low transverse cesarean, Obstet Gynecol, 95, 745
- Angeja, 2006, Chilean women's preferences regarding mode of delivery: which do they prefer and why?, BJOG, 113, 1253, 10.1111/j.1471-0528.2006.01069.x · DOI · Paper page
- Kaimal, 2011, Cost-effectiveness of elective induction of labor at 41 weeks in nulliparous women, Am J Obstet Gynecol, 204, 137.e1, 10.1016/j.ajog.2010.08.012 · DOI
- Caughey, 2003, Quantitative evaluation of preference for mode of delivery in pregnant Chilean women, Med Decis Making, 23, 634
- Kuppermann, 2000, Procedure-related miscarriages and Down syndrome–affected births: implications for prenatal testing based on women's preferences, Obstet Gynecol, 96, 511
- Heron, 2009, Deaths: final data for 2006, Natl Vital Stat Rep, 57, 1
- Alwan, 2009, Treatments for gestational diabetes, Cochrane Database Syst Rev, 3
- Ratner, 2008, Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions, J Clin Endocrinol Metab, 93, 4774, 10.1210/jc.2008-0772 · DOI · Paper page
- Stasenko, 2010, Postpartum follow-up for women with gestational diabetes mellitus, Am J Perinatol, 27, 737, 10.1055/s-0030-1253557 · DOI
- Stasenko, 2011, Patient counseling increases postpartum follow-up in women with gestational diabetes mellitus, Am J Obstet Gynecol, 204, 522.e1, 10.1016/j.ajog.2011.01.057 · DOI
Cited by
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Alfadhli, E. M. (2015) · Saudi Medical Journal · doi:10.15537/smj.2015.4.10307 · Cited by 245
Riestenberg, C., Jagasia, A., Markovic, D., Buyalos, R. P., & Azziz, R. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab613 · Cited by 210
Colagiuri, S., Falavigna, M., Agarwal, M. M., Boulvain, M., Coetzee, E., Hod, M., Meltzer, S. J., Metzger, B., Omori, Y., Rasa, I., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.02.012 · Cited by 132
“Another study [30] found that universal screening based on the IADPSG criteria showed a cost/QALY of $61,503, which may be acceptable in high resources settings but is not cost-effective for most countries based on the WHO guide (exceeding three”
BackgroundBrown, F. M., & Wyckoff, J. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0922-z · Cited by 122
“In a cost-effectiveness analysis, Mission et al. compared the one-step IADPSG criteria versus the two-step CC criteria using a Monte Carlo simulation to assess cost, effectiveness, and cost-effectiveness based on probabilities, costs, and benefits derived from the literature [63].”
MethodBenhalima, K., Mathieu, C., Damm, P., Van Assche, A., Devlieger, R., Desoye, G., Corcoy, R., Mahmood, T., Nizard, J., Savona-Ventura, C., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3615-7 · Cited by 72
“So far, two studies have addressed the cost effectiveness of GDM screening according to the IADPSG criteria using decision-analysis models for a US population [14, 15].”
MethodSelective rather than universal screening for gestational diabetes mellitus?
Miailhe, G., Kayem, G., Girard, G., Legardeur, H., & Mandelbrot, L. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.05.003 · Cited by 51
Ramezani Tehrani, F., Naz, M. S. G., Yarandi, R. B., & Behboudi-Gandevani, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040666 · Cited by 34
“Until now, there are not sufficient data to demonstrate the cost-effectiveness superiority of one screening and diagnostic approach over the other [75,76].”
BackgroundFadl, H., Saeedi, M., Montgomery, S., Magnuson, A., Schwarcz, E., Berntorp, K., Sengpiel, V., Storck-Lindholm, E., Strevens, H., Wikström, A.-K., et al. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2547-5 · Cited by 34
Gestational Diabetes: An Update 60 Years After O’Sullivan and Mahan
McIntyre, H. D., Kampmann, U., Dalsgaard Clausen, T., Laurie, J., & Ma, R. C. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae709 · Cited by 32
Economic evaluations of gestational diabetes mellitus screening: a systematic review
Mo, X., Gai Tobe, R., Takahashi, Y., Arata, N., Liabsuetrakul, T., Nakayama, T., & Mori, R. (2021) · Journal of Epidemiology · doi:10.2188/jea.je20190338 · Cited by 29
McIntyre, H. D., Oats, J. J. N., Kihara, A. B., Divakar, H., Kapur, A., Poon, L. C., & Hod, M. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13764 · Cited by 16
Tong, X., Yang, L., Jiang, C., Weng, Z., Zu, A., Hou, Y., Fang, Y., Yang, W., & Sun, S. (2023) · Reproductive Sciences · doi:10.1007/s43032-022-00904-3 · Cited by 16
Honnorat, D., Disse, E., Millot, L., Mathiotte, E., Claret, M., Charrie, A., Drai, J., Garnier, L., Maurice, C., Durand, E., et al. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.03.003 · Cited by 12
Metadata
- Authors
- Mission, J. F., Ohno, M. S., Cheng, Y. W., & Caughey, A. B.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 207
- Issue
- 4
- Pages
- 326.e1-326.e9
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2003722855
- Cited by
- 111
- References
- 12
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Institutes of Health
- University of California
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12 HD001262)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.